Differential impact of sodium butyrate forms on intestinal morphology, gene expression, and growth performance in broiler chickens under cold stress at high altitude
Broiler chickens reared at high altitudes face multiple stressors, including cold and hypoxia, which impair growth and gut health. Sodium butyrate (NaB) has emerged as a promising feed additive to mitigate these effects. This study evaluated the impact of non-encapsulated NaB and encapsulated (E-NaB) sodium butyrate on intestinal morphology, gene expression, and performance metrics in broilers under cold stress at high altitude. A total of 675 one-day-old Cobb broilers were assigned to nine dietary treatments: control, NaB (0.05% or 0.1%), E-NaB (0.05% or 0.1%), and their combinations. Birds were reared at 2100 m and subjected to cold stress. Growth performance, intestinal morphology, gene expression (MUC2, FABP2, GLUT2, TLR2, GPX, SOD1), and pulmonary hypertension syndrome (PHS) index (RV:TV ratio) were assessed. NaB supplementation improved the feed conversion ratio during the starter phase and overall rearing period (P < 0.05). Combined NaB+E-NaB treatments enhanced villus height, width, and surface area in the duodenum, jejunum, and ileum (P < 0.05). Gene expression analysis revealed upregulation of MUC2, FABP2, GLUT2, TLR2, GPX, and SOD1 in supplemented groups, particularly in combined treatments (P < 0.05). The RV:TV ratio, indicating PHS risk, was reduced in NaB0.1% and combined groups (P < 0.05). It is concluded that Sodium butyrate, especially in combined or encapsulated forms, improved gut health, modulated the expression of antioxidant-related genes (GPX and SOD1), and enhanced performance in broilers under cold stress and high-altitude conditions. These findings highlight NaB's potential as a strategic feed additive to enhance resilience in challenging environments.
Read more